Skip to main content

Advertisement

Log in

Combining accurate genetic and clinical information in breast cancer risk model

  • Letter to the Editor
  • Published:
Breast Cancer Research and Treatment Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

References

  1. Hartman M, Suo C, Lim WY, Miao H, Teo YY and Chia KS (2010) Ability to predict breast cancer in Asian women using a polygenic susceptibility model. Breast Cancer Res Treat. doi:10.1007/s10549-10010-11279-z (in press)

  2. Pharoah PD, Antoniou AC, Easton DF, Ponder BA (2008) Polygenes, risk prediction, and targeted prevention of breast cancer. N Engl J Med 358:2796–2803

    Article  PubMed  CAS  Google Scholar 

  3. Gerger A, Langsenlehner U, Renner W, Weitzer W, Eder T, Yazdani-Biuki B, Hofmann G, Samonigg H, Krippl P (2007) A multigenic approach to predict breast cancer risk. Breast Cancer Res Treat 104:159–164

    Article  PubMed  CAS  Google Scholar 

  4. Zheng SL, Sun J, Wiklund F, Smith S, Stattin P, Li G, Adami HO, Hsu FC, Zhu Y, Balter K, Kader AK, Turner AR, Liu W, Bleecker ER, Meyers DA, Duggan D, Carpten JD, Chang BL, Isaacs WB, Xu J, Gronberg H (2008) Cumulative association of five genetic variants with prostate cancer. N Engl J Med 358:910–919

    Article  PubMed  CAS  Google Scholar 

  5. Mealiffe ME, Stokowski RP, Rhees BK, Prentice RL, Pettinger M, Hinds DA (2010) Assessment of clinical validity of a breast cancer risk model combining genetic and clinical information. J Natl Cancer Inst 102:1618–1627

    Article  PubMed  CAS  Google Scholar 

  6. Zheng W, Wen W, Gao YT, Shyr Y, Zheng Y, Long J, Li G, Li C, Gu K, Cai Q, Shu XO, Lu W (2010) Genetic and clinical predictors for breast cancer risk assessment and stratification among Chinese women. J Natl Cancer Inst 102:972–981

    Article  PubMed  CAS  Google Scholar 

  7. Teixeira L, Julien C, Guimiot F (2008) Polygenes, risk prediction, and targeted prevention of breast cancer. N Engl J Med 359:1406–1407

    Article  PubMed  CAS  Google Scholar 

  8. Fanciulli M, Petretto E, Aitman TJ (2010) Gene copy number variation and common human disease. Clin Genet 77:201–213

    Article  PubMed  CAS  Google Scholar 

  9. Bassett AS, Scherer SW, Brzustowicz LM (2010) Copy number variations in schizophrenia: critical review and new perspectives on concepts of genetics and disease. Am J Psychiatry 167:899–914

    Article  PubMed  Google Scholar 

  10. Kuiper RP, Ligtenberg MJ, Hoogerbrugge N, Geurts van Kessel A (2010) Germline copy number variation and cancer risk. Curr Opin Genet Dev 20:282–289

    Article  PubMed  CAS  Google Scholar 

  11. Tchatchou S, Burwinkel B (2008) Chromosome copy number variation and breast cancer risk. Cytogenet Genome Res 123:183–187

    Article  PubMed  CAS  Google Scholar 

  12. Frank B, Bermejo JL, Hemminki K, Sutter C, Wappenschmidt B, Meindl A, Kiechle-Bahat M, Bugert P, Schmutzler RK, Bartram CR, Burwinkel B (2007) Copy number variant in the candidate tumor suppressor gene MTUS1 and familial breast cancer risk. Carcinogenesis 28:1442–1445

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgments

This research is supported by the 2009 Youth Foundation of Shanghai Public Health Bureau, the 2009 Youth Foundation of Shanghai Medical College, the Shanghai United Developing Technology Project of Municipal Hospitals (SHDC12010116), and the National Natural Science Foundation of China (30971143, 30972936, 81001169).

Conflict of interest

None.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Zhi-Ming Shao.

Additional information

Ke-Da Yu and Qi Fang have contributed equally to this study.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Yu, KD., Fang, Q. & Shao, ZM. Combining accurate genetic and clinical information in breast cancer risk model. Breast Cancer Res Treat 128, 283–285 (2011). https://doi.org/10.1007/s10549-011-1389-2

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10549-011-1389-2

Keywords

Navigation